Gambia vs Mexico: Cause of death, by non-communicable diseases, ages 60+
Gambia
59.3%
in 2021
Mexico
59.5%
in 2021
Gambia rank
157th
Mexico rank
155th
Cause of death, by non-communicable diseases, ages 60+ over time
- Gambia
- Mexico
How they compare
Mexico currently reports 59.5% against 59.3% in Gambia, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mexico ahead.
Gambia ranks 157th and Mexico ranks 155th of 185 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Gambia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 86.6% | 19.9% | Mexico |
| 2010s | 68.0% | 89.3% | 21.2% | Mexico |
| 2020s | 62.8% | 60.1% | 2.7% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Gambia or Mexico?
- Mexico, at 59.5% against 59.3% in Gambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Gambia and Mexico?
- 0.2%, with Mexico ahead.
- How many years of comparable data are there for Gambia and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Mexico rank globally for cause of death, by non-communicable diseases, ages 60+?
- Gambia ranks 157th and Mexico ranks 155th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.